.three 0.28 six 0.06m# 1.28 6 0.35 37.2 six four.three 38.0 6 23388095 three.7 30.two six 5.0 20.four six 4.three 1.five 6 0.3 34.8 6 4.3 20.7 6 four.1 1.7 6 0.3 0.54 6 0.10 0.73 6 0.21 37.4 six 4.two 41.two six 3.9 ,0.001 NS,0.001,0.001 NS NS NS 0.45 six 0.06 0.74 six 0.17 35.7 6 three.six 38.8 6 3.four 44.5 six 4.8 25.3 6 5.2 1.eight six 0.4 52.4 six eight.4 26.8 six 4.six 2.0 6 0.five 0.46 six 0.09 1.34 6 0.35 38.5 6 4.two 41.4 six four.6 ,0.001 NS NS,0.001 NS NS NS 0.41 6 0.07 1.27 six 0.29 36.eight six four.six 39.four six 4.two 55.7 6 14.0 30.3 6 four.7 1.9 six 0.five 0.26 six 0.11m

.three 0.28 6 0.06m# 1.28 6 0.35 37.two six four.three 38.0 six three.7 30.two 6 five.0 20.4 6 4.three 1.five six 0.three 34.8 6 4.three 20.7 six four.1 1.7 6 0.three 0.54 six 0.ten 0.73 6 0.21 37.four six four.2 41.two 6 3.9 ,0.001 NS,0.001,0.001 NS NS NS 0.45 six 0.06 0.74 6 0.17 35.7 six 3.six 38.8 six three.four 44.5 six 4.eight 25.3 6 5.2 1.eight six 0.4 52.4 6 eight.four 26.8 6 four.6 2.0 6 0.5 0.46 six 0.09 1.34 6 0.35 38.5 6 4.two 41.four six 4.six ,0.001 NS NS,0.001 NS NS NS 0.41 six 0.07 1.27 six 0.29 36.8 6 four.6 39.four six 4.two 55.7 six 14.0 30.3 six four.7 1.9 6 0.5 0.26 six 0.11m 1.81 6 0.67 35.four six 4.5 35.eight 6 3.8 59.9 six 14.six 31.4 six 4.0 1.9 six 0.5 58.9 six 11.3 29.8 6 5.0 2.1 six 0.six 0.45 6 0.11 1.58 6 0.55 39.0 6 four.9 41.3 six 5.five NS NS NS,0.001 NS NS 0.049 0.39 6 0.10 1.72 six 0.68 35.64 six four.8 38.0 6 4.2 Data are presented as suggests 6 SD; VE = ventilation; RR = respiratory rate; VT = tidal volume; VD = dead space volume; VCO2 = carbon dioxide production; PaCO2 = arterial carbon dioxide pressure; PETCO2 = End-tidal carbon dioxide stress; bpm = breaths per minute; $: p,0.05 vs. 250 mL; m: p,0.001 vs. 500 mL; : p,0.001 vs. 250 mL; &: p,0.01 vs.500 mL; #,0.01 vs. 250 mL. doi:ten.1371/journal.pone.0087395.t003 primitive chemoreceptor abnormalities as drivers of the alveolar hypoventilation observed in COPD patients. Thirdly, with the Yintercept we analyze an index of overall DS. However, in the present setting, we were able to change DS only by adding an external DS, so that we do not know if changes in PLV-2 physiological DS similarly influence the VEYint. Fourthly, VE changes during exercise are due to VCO2, VD/ VT and PaCO2 changes, and all may influence the VE vs. VCO2 relationship. In the present study, we added external DS, which at each step of exercise, was associated to an increase of VD/VT and PaCO2 resembling what happens during exercise in COPD patients. Therefore both PaCO2 and VD/VT changes have likely a role in the VE vs. VCO2 relationship changes we observed after adding DS. It is recognized that PaCO2 measurements were done only in HF patients and not in healthy subjects, but a different behaviour in healthy subjects is unlikely. Fifthly, the condition of VE at CO2 production equal 0, as such at the VEYint of the VE vs. VCO2 relationship, is a mathematical extrapolation with no physiological meaning. Moreover, absolute DS changes during exercise, so that also the VEYint value is likely close but different from the rest value. Indeed, we showed that VD tended to increase in HF patients and to reduce in healthy subjects during exercise without added DS. However, we suggest using VEYint as a tool to evaluate the presence of an increased DS, regardless of its physiological meaning with respect to rest and exercise. The adding of DS significantly reduced the external work produced in HF patients, while a not significant reduction was observed in normal subjects. Peak VO2 remained unchanged in both groups after adding DS; this finding suggests that added DS was associated to an increased work of breathing which, as a percentage of total work, seems to be greater in HF patients than in normal subjects. Estimation of Dead Space Ventilation HEART FAILURE PATIENTS ADDED DEAD SPACE +0 mL +250 mL 2865 9.6962.91 1563 1 ANOVA p value +500 mL 2964 13.2663.18 1663 1 VE/VCO2 slope VEYint RRYint Pentagastrin manufacturer VDYint VDmeas HEALTHY SUBJECTS VE/VCO2 slope VEYint RRYint VDYint VDmeas 2764 4.9861.63, construct consecutive coarse-grained time series,, determined by the scale factor, t, jt 1 X N Xi, 1j. For according to the equation: y ~ j t i~tz1 t scale one, the time series is simply the ori..3 0.28 6 0.06m# 1.28 6 0.35 37.two six four.3 38.0 six three.7 30.two 6 five.0 20.four six 4.three 1.5 6 0.three 34.8 six 4.three 20.7 6 four.1 1.7 six 0.three 0.54 6 0.ten 0.73 6 0.21 37.four 6 4.2 41.2 six three.9 ,0.001 NS,0.001,0.001 NS NS NS 0.45 6 0.06 0.74 6 0.17 35.7 6 three.six 38.8 6 three.4 44.5 6 4.eight 25.3 6 5.2 1.eight six 0.four 52.4 six eight.four 26.8 6 four.6 two.0 six 0.5 0.46 six 0.09 1.34 six 0.35 38.5 six four.2 41.4 six 4.six ,0.001 NS NS,0.001 NS NS NS 0.41 six 0.07 1.27 6 0.29 36.8 six 4.6 39.4 six four.2 55.7 six 14.0 30.3 six 4.7 1.9 six 0.5 0.26 6 0.11m 1.81 6 0.67 35.4 6 four.five 35.8 6 3.eight 59.9 6 14.six 31.4 six 4.0 1.9 6 0.five 58.9 six 11.three 29.8 6 5.0 2.1 6 0.six 0.45 6 0.11 1.58 6 0.55 39.0 6 four.9 41.three 6 5.5 NS NS NS,0.001 NS NS 0.049 0.39 six 0.10 1.72 6 0.68 35.64 six four.8 38.0 6 4.2 Data are presented as indicates six SD; VE = ventilation; RR = respiratory rate; VT = tidal volume; VD = dead space volume; VCO2 = carbon dioxide production; PaCO2 = arterial carbon dioxide pressure; PETCO2 = End-tidal carbon dioxide stress; bpm = breaths per minute; $: p,0.05 vs. 250 mL; m: p,0.001 vs. 500 mL; : p,0.001 vs. 250 mL; &: p,0.01 vs.500 mL; #,0.01 vs. 250 mL. doi:ten.1371/journal.pone.0087395.t003 primitive chemoreceptor abnormalities as drivers of the alveolar hypoventilation observed in COPD patients. Thirdly, with the Yintercept we analyze an index of overall DS. However, in the present setting, we were able to change DS only by adding an external DS, so that we do not know if changes in physiological DS similarly influence the VEYint. Fourthly, VE changes during exercise are due to VCO2, VD/ VT and PaCO2 changes, and all may influence the VE vs. VCO2 relationship. In the present study, we added external DS, which at each step of exercise, was associated to an increase of VD/VT and PaCO2 resembling what happens during exercise in COPD patients. Therefore both PaCO2 and VD/VT changes have likely a role in the VE vs. VCO2 relationship changes we observed after adding DS. It is recognized that PaCO2 measurements were done only in HF patients and not in healthy subjects, but a different behaviour in healthy subjects is unlikely. Fifthly, the condition of VE at CO2 production equal 0, as such at the VEYint of the VE vs. VCO2 relationship, is a mathematical extrapolation with no physiological meaning. Moreover, absolute DS changes during exercise, so that also the VEYint value is likely close but different from the rest value. Indeed, we showed that VD tended to increase in HF patients and to reduce in healthy subjects during exercise without added DS. However, we suggest using VEYint as a tool to evaluate the presence of an increased DS, regardless of its physiological meaning with respect to rest and exercise. The adding of DS significantly reduced the external work produced in HF patients, while a not significant reduction was observed in normal subjects. Peak VO2 remained unchanged in both groups after adding DS; this finding suggests that added DS was associated to an increased work of breathing which, as a percentage of total work, seems to be greater in HF patients than in normal subjects. Estimation of Dead Space Ventilation HEART FAILURE PATIENTS ADDED DEAD SPACE +0 mL +250 mL 2865 9.6962.91 1563 1 ANOVA p value +500 mL 2964 13.2663.18 1663 1 VE/VCO2 slope VEYint RRYint VDYint VDmeas HEALTHY SUBJECTS VE/VCO2 slope VEYint RRYint VDYint VDmeas 2764 4.9861.63, construct consecutive coarse-grained time series,, determined by the scale factor, t, jt 1 X N Xi, 1j. For according to the equation: y ~ j t i~tz1 t scale one, the time series is simply the ori.